Details for New Drug Application (NDA): 078470
✉ Email this page to a colleague
NDA 078470 describes ACARBOSE, which is a drug marketed by Avet Lifesciences, Dash Pharms, Hangzhou Zhongmei, Hikma, Impax Labs, Somerset Theraps Llc, Strides Pharma, and Watson Labs, and is included in eight NDAs. It is available from nine suppliers. Additional details are available on the ACARBOSE profile page.
The generic ingredient in ACARBOSE is acarbose. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the acarbose profile page.
The generic ingredient in ACARBOSE is acarbose. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the acarbose profile page.
Pharmacology for NDA: 078470
| Mechanism of Action | alpha Glucosidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 078470
Suppliers and Packaging for NDA: 078470
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ACARBOSE | acarbose | TABLET;ORAL | 078470 | ANDA | Hikma Pharmaceuticals USA Inc. | 0054-0140 | 0054-0140-25 | 100 TABLET in 1 BOTTLE (0054-0140-25) |
| ACARBOSE | acarbose | TABLET;ORAL | 078470 | ANDA | Hikma Pharmaceuticals USA Inc. | 0054-0141 | 0054-0141-25 | 100 TABLET in 1 BOTTLE (0054-0141-25) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | May 7, 2008 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | May 7, 2008 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | May 7, 2008 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
